Advertisements


Prana to start Phase 1 clinical trial study of PBT434

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 13th, 2018

Advaxis shares rise 68% after FDA lifts clinical hold on its drug trial

Shares of the biotech company Advaxis Inc. surged 68% in premarket trade on Friday after the Food and Drug Administration lifted a clinical hold on the company's phase 1/2 study for a cancer drug combination. The clinical hol.....»»

Category: topSource: marketwatchJul 13th, 2018

Biotech ETFs Surge on Biogen"s Positive Drug Trial Result

Biotech ETFs surge on Biogen's encouraging Phase 2 clinical study data for Alzheimer???s treatment. Biogen Inc. BIIB was a star performer in Friday’s trading session, as the stock rallied as much as 23.1% but closed a l.....»»

Category: worldSource: nytJul 9th, 2018

Catalyst Enrolls First Patient in Phase III Firdapse Study

Catalyst (CPRX) enrolls the first patient in its phase III clinical trial (MSK-002) to evaluate the efficacy and safety of Firdapse in patients with MuSK antibody positive Myasthenia Gravis. Catalyst Pharmaceuticals, Inc. CPRX, enroled.....»»

Category: worldSource: nytApr 20th, 2018

Start of Phase 3 trial for EB-101 an important catalyst for Abeona, says Citi

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 17th, 2018

Akari Announces First Quarter 2018 Financial Results and Update on its Growing Pipeline of Phase II and Phase III Clinical Trials

Opened three clinical trials in 2018 Trials in which complement dysregulation is the primary disease driver CAPSTONE, the Phase III trial in na├»ve paroxysmal nocturnal hemoglobinuria (PNH), in which patient treatment has commenced Phase II U.S. trial f.....»»

Category: earningsSource: benzingaAug 17th, 2018

Neuralstem Provides Business Update and Reports Second Quarter 2018 Fiscal Results

- Phase 2 clinical trial initi.....»»

Category: earningsSource: benzingaAug 15th, 2018

Oragenics resumes Phase 2 clinical trial of AG013

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 15th, 2018

30 Stocks Moving In Wednesday"s Pre-Market Session

Gainers Oragenics Inc (NYSE: OGEN) rose 27.2 percent to $0.63 in pre-market trading after the company disclosed that it has resumed Phase 2 clinical trial of AG013 in oral mucositis following positive routine safety review. read more.....»»

Category: blogSource: benzingaAug 15th, 2018

Aevi Genomics Medicine completed enrollment for Phase 2 ASCEND clinical trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 14th, 2018

Iterum Therapeutics initiates SURE 1 Phase 3 clinical trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 9th, 2018

Audentes Therapeutics Reports Second Quarter 2018 Financial Results and Provides Update on ASPIRO, the Phase 1/2 Clinical Trial of AT132 in Patients with X-Linked Myotubular Myopathy

Audentes Therapeutics Reports Seco.....»»

Category: earningsSource: benzingaAug 7th, 2018

Denali announces "positive" clinical results from Phase 1 DNL201 study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 1st, 2018

BioLineRx initiates Phase 1/2a clinical study for AGI-134

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 1st, 2018

Biohaven enrolls first patient in trigriluzole Phase 2/3 clinical trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 1st, 2018

Emergent BioSolutions initiates Phase 1 clinical study of anti-Zika drug

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 31st, 2018

Lantheus, GE Healthcare start Phase 3 trial of Flurpiridaz F

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 31st, 2018

Otonomy initiates Phase 3 clinical trial of Otividex

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 26th, 2018

Aldeyra enrolls first patient in Phase 3 clinical trial of dermal reproxalap

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 24th, 2018

BeiGene initiates Phase 3 clinical trial of pamiparib

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 24th, 2018

Merck announces results from Phase 3 Drive-Forward clinical trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 24th, 2018